111 related articles for article (PubMed ID: 12295471)
21. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
22. Introducing new contraceptives.
Segal SJ; Coutinho E
Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
[TBL] [Abstract][Full Text] [Related]
23. [Oral miltefosine to treat leishmaniasis].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():207-17. PubMed ID: 17361856
[TBL] [Abstract][Full Text] [Related]
24. Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective.
Sinha PK; Ranjan A; Singh VP; Das VN; Pandey K; Kumar N; Verma N; Lal CS; Sur D; Manna B; Bhattacharya SK
J Infect; 2006 Jul; 53(1):60-4. PubMed ID: 16269185
[TBL] [Abstract][Full Text] [Related]
25. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
Hentschel CC
Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
[No Abstract] [Full Text] [Related]
26. [Visceral leishmaniasis: clinical sensitivity and resistance to various therapeutic agents].
Janvier F; Morillon M; Olliaro P
Med Trop (Mars); 2008 Feb; 68(1):89-101. PubMed ID: 18478781
[TBL] [Abstract][Full Text] [Related]
27. Management of visceral leishmaniasis: Indian perspective.
Agrawal S; Rai M; Sundar S
J Postgrad Med; 2005; 51 Suppl 1():S53-7. PubMed ID: 16519257
[TBL] [Abstract][Full Text] [Related]
28. Can AIDS drugs be afforded?
Afr Health; 1997 Nov; 20(1):7. PubMed ID: 12348380
[TBL] [Abstract][Full Text] [Related]
29. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
[TBL] [Abstract][Full Text] [Related]
30. Malaria: radical treatment for falciparum malaria in chloroquine resistant strain areas.
Sehgal PN
Health Millions; 1998; 24(6):18-9. PubMed ID: 12321868
[TBL] [Abstract][Full Text] [Related]
31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
32. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of visceral leishmaniasis].
Foti G
Minerva Med; 2001 Aug; 92(4):245-9. PubMed ID: 11535968
[TBL] [Abstract][Full Text] [Related]
34. Towards a rational drug policy for malaria.
Sehgal PN
Health Millions; 1998; 24(4):27, 29. PubMed ID: 12349581
[TBL] [Abstract][Full Text] [Related]
35. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
[TBL] [Abstract][Full Text] [Related]
36. In sickness or in health: TDR's partners. 8. Kenya Medical Research Institute (KEMRI).
TDR News; 1998 Jun; (56):8. PubMed ID: 12321804
[TBL] [Abstract][Full Text] [Related]
37. Emerging infectious disease: global response, global alert.
Nakajima H
Health Millions; 1997; 23(2):19. PubMed ID: 12348002
[TBL] [Abstract][Full Text] [Related]
38. Miltefosine Zentaris.
Kaminsky R
Curr Opin Investig Drugs; 2002 Apr; 3(4):550-4. PubMed ID: 12090722
[TBL] [Abstract][Full Text] [Related]
39. Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.
Olliaro P; Sundar S
Trop Med Int Health; 2009 Jan; 14(1):88-92. PubMed ID: 19121150
[TBL] [Abstract][Full Text] [Related]
40. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
